Iran's Shahid Beheshti University leading force in production of Favipiravir

Business Materials 26 August 2020 15:54 (UTC +04:00)
Iran's Shahid Beheshti University leading force in production of Favipiravir

TEHRAN, Iran, Aug.26


The Shahid Beheshti University of Medical Science was the first working group that developed technical knowledge of producing Favipiravir medicine in Iran to fight Coronavirus while it was a leading force to design other related medicines, the head of School of Pharmacy in the Shahid Beheshti University of Medical Science, Hossein Vahidi said, Trend reports citing Mehr News Agency.

"The formulation of recommended medicine for fighting Coronavirus was designed by pharmacists as soon as possible and sent to production centers," Vahidi said
"Favipiravir medicine used to be produced by a Japanese company to cure influenza has shown promising results in recovery of corona patients, as a result, the National Headquarters for Fight against Coronavirus has supported the production process of the drug that was developed by scientists in Shahid Beheshti University in short notice. Following this, the Health Ministry produced and supplied it to hospitals and healthcare centers," he stated.

"Favipiravir was produced in scientific labs and was compared to the Japanese version," he added.

"Producing coronavirus testing kits and disinfectants was another milestone by scientists of the university that was achieved by cooperating with the private sector," he noted.

" One of the issues faced at the beginning of the outbreak was a shortage of disinfectants. Local pharmaceutical companies produced sanitizers based on the World Health Organization's recommendations and provided them to people and hospitals. Since then almost no hospital faced a medical shortage." Vahidi said.

"All the pharmacists have provided superb services during the Coronavirus crisis. Pharmacies are at the front line in the fight against COVID-19," he added.